Pharma commercial organizations are facing a fundamental shift. Fragmented data, evolving regulations and rising expectations ...

Two decades of innovation reveal mixed findings for quality, cost, and utilization—and unclear ways to resolve. The results are in on the impact of value-based payments (VBP) and once again, they're ...

Biopharmaceutical companies are looking for go-to-market approaches that go beyond customer expectations. Starting with a revolutionized technology platform allows these organizations to create value ...

What’s the best way to improve commercial performance? For biopharma companies, according to a report from Accenture, the answer is investment and innovation. In a five-year study of 15 drugmakers, ...

Meta Platforms Inc. is planning to release a commercial version of its artificial intelligence model designed for commercial use, according to a report today from the Financial Times. Meta released ...